Cargando…
Why is there persistent disease despite biologic therapy? Importance of early intervention
This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of d...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075238/ https://www.ncbi.nlm.nih.gov/pubmed/25167379 http://dx.doi.org/10.1186/ar4594 |
_version_ | 1782323310522007552 |
---|---|
author | Emery, Paul |
author_facet | Emery, Paul |
author_sort | Emery, Paul |
collection | PubMed |
description | This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of disease can achieve a clinical remission rate of 70% and a response rate of above 95%. |
format | Online Article Text |
id | pubmed-4075238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40752382014-12-26 Why is there persistent disease despite biologic therapy? Importance of early intervention Emery, Paul Arthritis Res Ther Commentary This short article hypothesizes that the major reason for persistent disease despite biologic therapy is the inappropriately late timing of therapy with biologic agents. There is clear evidence to support this hypothesis. This short review will indicate that patients treated at an earlier phase of disease can achieve a clinical remission rate of 70% and a response rate of above 95%. BioMed Central 2014 2014-06-26 /pmc/articles/PMC4075238/ /pubmed/25167379 http://dx.doi.org/10.1186/ar4594 Text en Copyright © 2014 Emery; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 6 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Emery, Paul Why is there persistent disease despite biologic therapy? Importance of early intervention |
title | Why is there persistent disease despite biologic therapy? Importance of early intervention |
title_full | Why is there persistent disease despite biologic therapy? Importance of early intervention |
title_fullStr | Why is there persistent disease despite biologic therapy? Importance of early intervention |
title_full_unstemmed | Why is there persistent disease despite biologic therapy? Importance of early intervention |
title_short | Why is there persistent disease despite biologic therapy? Importance of early intervention |
title_sort | why is there persistent disease despite biologic therapy? importance of early intervention |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075238/ https://www.ncbi.nlm.nih.gov/pubmed/25167379 http://dx.doi.org/10.1186/ar4594 |
work_keys_str_mv | AT emerypaul whyistherepersistentdiseasedespitebiologictherapyimportanceofearlyintervention |